PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.15%
Revenue growth 1.25-1.5x LSCC's 7.98%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
8.67%
Gross profit growth similar to LSCC's 8.54%. Walter Schloss would assume both firms track common industry trends.
-18.95%
Negative EBIT growth while LSCC is at 25.36%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-14.93%
Negative operating income growth while LSCC is at 25.36%. Joel Greenblatt would press for urgent turnaround measures.
-47.61%
Negative net income growth while LSCC stands at 35.59%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-48.68%
Negative EPS growth while LSCC is at 29.41%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-47.22%
Negative diluted EPS growth while LSCC is at 37.50%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.47%
Share reduction more than 1.5x LSCC's 4.67%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-4.07%
Reduced diluted shares while LSCC is at 3.77%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
2.45%
Dividend growth of 2.45% while LSCC is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-23.75%
Negative OCF growth while LSCC is at 301.03%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-222.99%
Negative FCF growth while LSCC is at 547.49%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
42.96%
10Y revenue/share CAGR under 50% of LSCC's 171.62%. Michael Burry would suspect a lasting competitive disadvantage.
-19.24%
Negative 5Y CAGR while LSCC stands at 17.50%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
13.52%
3Y revenue/share CAGR above 1.5x LSCC's 6.39%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
2418.16%
10Y OCF/share CAGR above 1.5x LSCC's 273.01%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-16.24%
Negative 5Y OCF/share CAGR while LSCC is at 107.62%. Joel Greenblatt would question the firm’s operational model or cost structure.
-19.88%
Negative 3Y OCF/share CAGR while LSCC stands at 456.80%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
7472.52%
Net income/share CAGR above 1.5x LSCC's 122.68% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
105.66%
Positive 5Y CAGR while LSCC is negative. John Neff might view this as a strong mid-term relative advantage.
-64.38%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
287.85%
10Y equity/share CAGR at 75-90% of LSCC's 373.55%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
182.94%
5Y equity/share CAGR above 1.5x LSCC's 75.15%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
76.79%
Positive short-term equity growth while LSCC is negative. John Neff sees a strong advantage in near-term net worth buildup.
15.66%
Dividend/share CAGR of 15.66% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-4.26%
Negative 5Y dividend/share CAGR while LSCC stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-1.77%
Negative near-term dividend growth while LSCC invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
12.58%
Our AR growth while LSCC is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.11%
Inventory growth well above LSCC's 16.92%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-6.23%
Negative asset growth while LSCC invests at 21.03%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.27%
We have a declining book value while LSCC shows 29.80%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
4.89%
Debt growth of 4.89% while LSCC is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
33.25%
R&D growth drastically higher vs. LSCC's 2.66%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
13.25%
SG&A growth well above LSCC's 3.86%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.